Kazuhiko Arima

7.0k total citations · 3 hit papers
84 papers, 5.3k citations indexed

About

Kazuhiko Arima is a scholar working on Physiology, Immunology and Dermatology. According to data from OpenAlex, Kazuhiko Arima has authored 84 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Physiology, 38 papers in Immunology and 33 papers in Dermatology. Recurrent topics in Kazuhiko Arima's work include Asthma and respiratory diseases (42 papers), Dermatology and Skin Diseases (33 papers) and Allergic Rhinitis and Sensitization (19 papers). Kazuhiko Arima is often cited by papers focused on Asthma and respiratory diseases (42 papers), Dermatology and Skin Diseases (33 papers) and Allergic Rhinitis and Sensitization (19 papers). Kazuhiko Arima collaborates with scholars based in Japan, United States and France. Kazuhiko Arima's co-authors include Kenji Izuhara, Shino Hanabuchi, Yong‐Jun Liu, Kui Shin Voo, Shuji Toda, Tomoki� Ito, Laura Bover, Shoichiro Ohta, Yui-Hsi Wang and Yi-Hong Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Kazuhiko Arima

80 papers receiving 5.3k citations

Hit Papers

Identification of IL-17-producing FOXP3+regulatory T cell... 2006 2026 2012 2019 2009 2006 2007 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Identification of IL-17-producing FOXP3+regulatory T cells in humans
    2009 559 citations Kui Shin Voo, Yui-Hsi Wang et al. profile →
  2. Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals
    2006 530 citations Kazuhiko Arima, Shuji Toda et al. profile →
  3. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC–activated Th2 memory cells
    2007 515 citations Yui-Hsi Wang, Kui Shin Voo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuhiko Arima Japan 37 2.7k 1.8k 1.2k 1.1k 733 84 5.3k
Shoichiro Ohta Japan 39 1.5k 0.5× 1.7k 0.9× 438 0.4× 629 0.6× 386 0.5× 130 4.6k
Makoto Sugaya Japan 41 2.8k 1.1× 595 0.3× 2.2k 1.9× 534 0.5× 1.2k 1.6× 237 6.0k
Itsuo Iwamoto Japan 51 4.4k 1.6× 2.5k 1.4× 581 0.5× 997 0.9× 1.1k 1.4× 167 7.7k
Laura Maggi Italy 39 4.3k 1.6× 857 0.5× 522 0.4× 457 0.4× 869 1.2× 92 6.9k
Karin Hartmann Germany 39 3.9k 1.5× 1.0k 0.6× 687 0.6× 1.6k 1.5× 374 0.5× 165 5.9k
Matthew A. Sleeman United States 33 1.5k 0.5× 1.0k 0.6× 362 0.3× 553 0.5× 473 0.6× 82 3.8k
Jérôme Pène France 34 3.1k 1.1× 1.5k 0.8× 819 0.7× 1.1k 1.0× 644 0.9× 76 5.4k
Martin Willheim Austria 38 1.7k 0.6× 749 0.4× 297 0.3× 849 0.8× 511 0.7× 89 4.1k
Koichi Yanaba Japan 37 4.9k 1.8× 458 0.3× 1.0k 0.9× 469 0.4× 1.0k 1.4× 125 8.1k
Jean‐David Bouaziz France 30 3.6k 1.3× 470 0.3× 983 0.8× 438 0.4× 616 0.8× 171 6.1k

Countries citing papers authored by Kazuhiko Arima

Since Specialization
Citations

This map shows the geographic impact of Kazuhiko Arima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuhiko Arima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuhiko Arima more than expected).

Fields of papers citing papers by Kazuhiko Arima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuhiko Arima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuhiko Arima. The network helps show where Kazuhiko Arima may publish in the future.

Co-authorship network of co-authors of Kazuhiko Arima

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuhiko Arima. A scholar is included among the top collaborators of Kazuhiko Arima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuhiko Arima. Kazuhiko Arima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Igarashi, Atsuyuki, et al.. (2025). Current Status of Prurigo Nodularis in Japan: A Retrospective Study Using a Health Insurance Claims Database. Journal of Clinical Medicine. 14(6). 1872–1872. 1 indexed citations
2.
Murota, Hiroyuki, et al.. (2024). Current clinical practice of prurigo nodularis in Japan: A cross‐sectional web‐survey among dermatologists. The Journal of Dermatology. 52(2). 348–352. 1 indexed citations
3.
4.
Igawa, Ken, et al.. (2023). Reduction in hospitalisations with dupilumab in Japanese adults with atopic dermatitis in a real‐world setting. SHILAP Revista de lepidopterología. 2(3). 543–548.
5.
Murota, Hiroyuki, et al.. (2023). Disease burden and treatment satisfaction in patients with prurigo nodularis in Japan. The Journal of Dermatology. 51(2). 223–233. 7 indexed citations
6.
Ohya, Yukihiro, et al.. (2023). The disease burden of pediatric patients with atopic dermatitis in Japan. Pediatric Dermatology. 40(5). 851–856. 7 indexed citations
7.
Saeki, Hidehisa, Hiroyuki Fujita, Katsuhisa Suzuki, & Kazuhiko Arima. (2023). Safety and effectiveness of dupilumab in the real‐world treatment of atopic dermatitis in Japan: 1‐year interim analysis from a post‐marketing surveillance. SHILAP Revista de lepidopterología. 6(3). 78–87. 3 indexed citations
8.
Nakahara, Takeshi, et al.. (2023). Evaluating the usefulness of the Atopic Dermatitis Control Tool for assessing disease control in individuals with atopic dermatitis in Japan. British Journal of Dermatology. 190(1). 123–125. 2 indexed citations
9.
Kamal, Mohamed, John D. Davis, Pavel Kovalenko, et al.. (2022). Pharmacokinetics, pharmacodynamics, and exposure–efficacy of dupilumab in adults with atopic dermatitis. Clinical and Translational Science. 15(10). 2342–2354. 4 indexed citations
10.
Tohda, Yuji, Yoichi Nakamura, Takao Fujisawa, et al.. (2022). Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study. Allergology International. 72(1). 89–99. 5 indexed citations
11.
Haddad, El‐Bdaoui, Sonya Cyr, Kazuhiko Arima, et al.. (2022). Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis. Dermatology and Therapy. 12(7). 1501–1533. 47 indexed citations
12.
Tohda, Yuji, Yoichi Nakamura, Takao Fujisawa, et al.. (2020). Dupilumab efficacy and safety in Japanese patients with uncontrolled, moderate-to-severe asthma in the phase 3 LIBERTY ASTHMA QUEST study. Allergology International. 69(4). 578–587. 15 indexed citations
13.
Izuhara, Kenji, Hisako Matsumoto, Shoichiro Ohta, et al.. (2015). Recent developments regarding periostin in bronchial asthma. Allergology International. 64. S3–S10. 48 indexed citations
14.
Uchida, Masaru, Hiroshi Shiraishi, Shoichiro Ohta, et al.. (2012). Periostin, a Matricellular Protein, Plays a Role in the Induction of Chemokines in Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 46(5). 677–686. 139 indexed citations
15.
Arima, Kazuhiko, Norihiko Watanabe, Shino Hanabuchi, et al.. (2010). Distinct Signal Codes Generate Dendritic Cell Functional Plasticity. Science Signaling. 3(105). ra4–ra4. 111 indexed citations
16.
Hanabuchi, Shino, Tomoki� Ito, Norihiko Watanabe, et al.. (2010). Thymic Stromal Lymphopoietin-Activated Plasmacytoid Dendritic Cells Induce the Generation of FOXP3+ Regulatory T Cells in Human Thymus. The Journal of Immunology. 184(6). 2999–3007. 156 indexed citations
17.
Buglio, Daniela, Georgios Georgakis, Shino Hanabuchi, et al.. (2008). Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines. Blood. 112(4). 1424–1433. 133 indexed citations
18.
Arima, Kazuhiko, Kazuo Sato, Go Tanaka, et al.. (2005). Characterization of the Interaction between Interleukin-13 and Interleukin-13 Receptors. Journal of Biological Chemistry. 280(26). 24915–24922. 71 indexed citations
19.
Seki, Noriyasu, Wataru Suzuki, Katsuhiko Hayashi, et al.. (2004). IL-4-Induced GATA-3 Expression Is a Time-Restricted Instruction Switch for Th2 Cell Differentiation. The Journal of Immunology. 172(10). 6158–6166. 57 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shoichiro Ohta Breakdown of academic impact, for papers by Makoto Sugaya Breakdown of academic impact, for papers by Itsuo Iwamoto Breakdown of academic impact, for papers by Laura Maggi Breakdown of academic impact, for papers by Karin Hartmann Breakdown of academic impact, for papers by Matthew A. Sleeman Breakdown of academic impact, for papers by Jérôme Pène Breakdown of academic impact, for papers by Martin Willheim Breakdown of academic impact, for papers by Koichi Yanaba Breakdown of academic impact, for papers by Jean‐David Bouaziz
Rankless by CCL
2026